Illuminating the Black Box: The Real Risk of Serious Infection With Inflammatory Bowel Disease Therapies

被引：7
|
作者：
Lynn, Amanda M. [1 ]
Loftus, Edward V., Jr. [1 ]
机构：
[1] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St Southwest, Rochester, MN 55905 USA
来源：
GASTROENTEROLOGY | 2018年 / 155卷 / 02期
关键词：
CROHNS-DISEASE; COMBINATION THERAPY; INFLIXIMAB; AZATHIOPRINE;
D O I：
10.1053/j.gastro.2018.06.053
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：262 / 265
页数：4
相关论文
共 50 条
  • [1] REAL WORLD COMPARATIVE RISK OF SERIOUS INFECTION WITH ADALIMUMAB, VEDOLIZUMAB, AND INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Osterman, Mark T.
    Long, Millie D.
    Singh, Siddharth
    Meyer, Nicole
    Feng, Chaoling
    Higgins, Kate
    Hepp, Zsolt
    Arikan, Dilek
    Wang, Anthony
    Feagan, Brian G.
    GASTROENTEROLOGY, 2018, 154 (06) : S365 - S365
  • [2] Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis
    Tassone, Daniel
    Basnayake, Chamara
    Wright, Emily
    Lust, Mark
    Kamm, Michael A.
    Niewiadomski, Ola
    Schulberg, Julien
    Flanagan, Emma
    Samyue, Tamie
    Fry, Stephanie
    Malcolm, Ruth
    Stanley, Annalise
    Thompson, Alexander J.
    Connell, William R.
    Ding, Nik S. S.
    INTERNAL MEDICINE JOURNAL, 2024, 54 (03) : 446 - 454
  • [3] Risk of Infections of Biological Therapies with Accent on Inflammatory Bowel Disease
    Nanau, Radu M.
    Cohen, Lawrence B.
    Neuman, Manuela G.
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2014, 17 (04): : 485 - 531
  • [4] Liver Disease in Cystic Fibrosis: Illuminating the Black Box
    Colombo, Carla
    Alicandro, Gianfranco
    HEPATOLOGY, 2019, 69 (04) : 1379 - 1381
  • [5] Incidence and risk factors of serious viral infections in inflammatory bowel disease
    Wisniewski, A.
    Landman, C.
    Kirchgesner, J.
    Bourrier, A.
    Nion-Larmurier, I.
    Sokol, H.
    Seksik, P.
    Cosnes, J.
    Beaugerie, L.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S176 - S177
  • [6] Incidence and Risk Factors of Serious Viral Infections in Inflammatory Bowel Disease
    Wisniewski, Andrew
    Landman, Cecilia
    Kirchgesner, Julien
    Bourrier, Anne
    Nion-Larmurier, Isabelle
    Sokol, Harry
    Seksik, Philippe
    Cosnes, Jacques
    Beaugerie, Laurent
    GASTROENTEROLOGY, 2016, 150 (04) : S225 - S225
  • [7] Cytomegalovirus Infection Increases the Risk for Inflammatory Bowel Disease
    Verdonk, Robert C.
    Haagsma, Elizabeth B.
    Kleibeuker, Jan H.
    Dijkstra, Gerard
    Sudan, Debra L.
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (06): : 3098 - 3098
  • [8] Infection Risk Among Elderly with Inflammatory Bowel Disease
    Taleban, Sasha
    PRACTICAL GASTROENTEROLOGY, 2015, 39 (02) : 28 - 36
  • [9] Comparative Risk of Serious Infection With Vedolizumab vs Anti-Tumor Necrosis Factors in Inflammatory Bowel Disease
    Dai, Cong
    Huang, Yu-hong
    Jiang, Min
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (01): : 259 - 259
  • [10] Phosphodiesterase inhibitors and inflammatory bowel disease: emerging therapies in inflammatory bowel disease
    Keshavarzian, Ali
    Mutlu, Ece
    Guzman, Juan P.
    Forsyth, Christopher
    Banan, Ali
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (09) : 1489 - 1506
12345